The Lancet18h
Management and mechanisms of eosinophil action in asthma: mind the gap?
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Healio4d
Top in allergy/asthma: Dupilumab ineffective for peanut desensitization; asthma blood test
Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind ...
Medscape5y
Moderate to Severe Asthma: News
Medscape Medical News, May 16, 2019 Alert European Commission OKs Dupilumab for Severe Asthma Dupilumab is for patients with moderate-to-severe asthma and increased blood eosinophil and/or raised ...
psychiatryadvisor.com18d
In Atopic Dermatitis, Dupilumab Use Linked to Less Sleep, Psychiatric Disorders
Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.
pharmaphorum6d
NICE changes stance on Sanofi's Dupixent for severe asthma
18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug. The final appraisal ...